Tuesday, October 17, 2023 6:47:18 AM
what did that proof Jacky?
Because we all know how markets and manipulater reacts after a "nice" longer timeline for relatively sure new shortpositions in the next 4-8 weeks!
So,some longs may have anticipated to sell 10 / 20 / even more % of their investment to buyback later and get more shares! sadly, excactly on that day i was away from the screen, i would have done the same with a very small amount of my holding.
On the other hand, some announcements could happen in that period of time (nature articel, partnership, MTD news, or even thinks we have not on our agenda)
So , some longs may try to optimize their portfolio and in the long run: Our shareprice will have fair value anyway.
SP end of 2023, SP after GBM approval in th UK, SP after partnership/s, after other RA, after combo results (spring 24) after other cancers . . . . you name it
Because we all know how markets and manipulater reacts after a "nice" longer timeline for relatively sure new shortpositions in the next 4-8 weeks!
So,some longs may have anticipated to sell 10 / 20 / even more % of their investment to buyback later and get more shares! sadly, excactly on that day i was away from the screen, i would have done the same with a very small amount of my holding.
On the other hand, some announcements could happen in that period of time (nature articel, partnership, MTD news, or even thinks we have not on our agenda)
So , some longs may try to optimize their portfolio and in the long run: Our shareprice will have fair value anyway.
SP end of 2023, SP after GBM approval in th UK, SP after partnership/s, after other RA, after combo results (spring 24) after other cancers . . . . you name it
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
